Patent · US Active

Modulation of MRTF-A activity in pathologic fibrosis and wound healing

US9937156B2 · kind B2 · utility

0Cited by

0References

28Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Eric Small · Chandler, US
Eric Olson · Dallas, US

Key dates

Filing date	Oct 16, 2014
Grant date	Apr 10, 2018
Priority date	—
Expiry date	Oct 16, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/412
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure concerns uses for isoxazole compounds or salts or analogs thereof for the treatment of wounds. The present disclosure also concerns devices for delivering a isoxazole compound or salts or an analogs thereof to a wound site.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.